LUCHETTI GENTILONI, Michele Maria
 Distribuzione geografica
Continente #
NA - Nord America 6.385
EU - Europa 3.283
AS - Asia 2.896
SA - Sud America 686
AF - Africa 205
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.469
Nazione #
US - Stati Uniti d'America 6.279
SG - Singapore 1.002
VN - Vietnam 617
RU - Federazione Russa 587
BR - Brasile 525
CN - Cina 497
IT - Italia 471
UA - Ucraina 456
SE - Svezia 383
DE - Germania 302
IE - Irlanda 273
HK - Hong Kong 219
FR - Francia 207
DK - Danimarca 163
TR - Turchia 162
FI - Finlandia 141
GB - Regno Unito 139
KR - Corea 89
IN - India 77
CI - Costa d'Avorio 73
AR - Argentina 55
MA - Marocco 53
CA - Canada 49
BD - Bangladesh 48
MX - Messico 40
PL - Polonia 36
IQ - Iraq 30
ZA - Sudafrica 29
JP - Giappone 27
NL - Olanda 27
EC - Ecuador 25
CO - Colombia 24
AT - Austria 23
BE - Belgio 19
ID - Indonesia 18
VE - Venezuela 17
UZ - Uzbekistan 16
PY - Paraguay 14
SA - Arabia Saudita 14
ES - Italia 13
MY - Malesia 13
TN - Tunisia 13
CL - Cile 11
KE - Kenya 11
LT - Lituania 10
PH - Filippine 10
OM - Oman 8
AU - Australia 7
EG - Egitto 7
IL - Israele 6
PK - Pakistan 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
TW - Taiwan 5
BY - Bielorussia 4
CG - Congo 4
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
PE - Perù 4
ET - Etiopia 3
GR - Grecia 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KH - Cambogia 2
MD - Moldavia 2
PS - Palestinian Territory 2
SN - Senegal 2
BS - Bahamas 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 13.466
Città #
Ashburn 929
Chandler 712
Singapore 620
Jacksonville 474
Dallas 363
Fairfield 306
Dublin 268
Des Moines 263
Boardman 257
Ho Chi Minh City 220
San Jose 215
Hong Kong 207
Wilmington 185
New York 182
The Dalles 147
Woodbridge 147
Beijing 144
Hanoi 136
Ann Arbor 126
Seattle 118
Houston 115
Lauterbourg 108
Moscow 108
Lawrence 107
Princeton 107
San Mateo 103
Los Angeles 96
Centro 88
Cambridge 75
Abidjan 73
Hefei 53
São Paulo 48
Munich 47
San Diego 46
Helsinki 44
Redmond 42
Orem 41
Buffalo 39
Council Bluffs 38
Da Nang 36
Turin 36
Ancona 31
Warsaw 30
London 29
Brooklyn 25
Haiphong 25
Chennai 23
Turku 23
Denver 22
Frankfurt am Main 21
Rome 21
Guangzhou 20
Montreal 20
Rio de Janeiro 20
Santa Clara 19
Washington 19
Chicago 18
Johannesburg 18
Milan 18
Norwalk 18
Tokyo 18
Brussels 17
Pune 17
Wuhan 17
Boston 16
Marche 16
Porto 16
Stockholm 16
Manchester 15
Belo Horizonte 14
Mexico City 14
Shanghai 14
Hải Dương 13
Poplar 13
Tashkent 13
Amsterdam 12
Phoenix 11
Vienna 11
Columbus 10
Nuremberg 10
Quito 10
San Francisco 10
Toronto 10
Atlanta 9
Nairobi 9
Brasília 8
Curitiba 8
Goiânia 8
Guayaquil 8
Indianapolis 8
Istanbul 8
Mumbai 8
Porto Alegre 8
Ankara 7
Baghdad 7
Biên Hòa 7
Can Tho 7
Erbil 7
Fortaleza 7
Querétaro 7
Totale 8.333
Nome #
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 191
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 186
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 182
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 180
Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma 169
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 168
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 166
c-MYB transactivates the alpha 2(I) collagen gene. 161
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth 161
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 160
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 157
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 156
Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile 155
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 152
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 151
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 150
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 149
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 148
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 147
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 146
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 143
A new HLA-DRB1*11 allele, DRB1*1144, identified by cloning and sequencing 142
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 142
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 141
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 140
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 139
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 137
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 137
Skin Involvement in SARS-CoV-2 Infection: Case Series 136
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 135
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 135
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 134
Certolizumab pegol for the treatment of psoriasis 134
6. Tenoxicam and ketoprofen level monitoring with high-performance liquid chromatography in patients affected by rheumatoid arthritis 133
MR imaging of rheumatoid hand lesions: comparison with conventional radiology in 31 patients 132
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 132
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 132
21. The Myb oncogene family of transcription factors: potent regulators of hematopoietic cells proliferation and differentiation. 130
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 128
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 126
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 126
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 126
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 124
Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis. 124
Low number of complement C3B/C4B receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis 123
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 123
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 122
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 122
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 122
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 121
5-methylcytosine content of DNA in blood and synovial mononuclear cells and in synovial tissue from patients affected by rheumatic autoimmune disease. 120
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 119
C-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation 118
Stimulatory autoantibodies against PDGF receptors in Scleroderma 117
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 117
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 116
Dissociation between p93-B-myb and p75-c-myb expression during proliferation and differentiation of human myeloid cells lines 115
c-myb, but not B-myb, upregulates alfa-1(I) and alfa-2(I) collagen gene expression in fibroblasts 114
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 113
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 113
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 113
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 111
Biologics in inflammatory and immunomediated arthritis 110
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 109
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 109
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 109
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 109
Effect of high-doses intravenous immunoglobulin in rheumatoid arthritis 107
SpA and PsA basic and translational research OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy 107
Preliminary validation of the Simplified Psoriatic Arthritis Radiographic Score (SPARS) 104
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 103
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 101
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 100
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 99
Collagen loss and impaired wound healing is associated with c-Myb deficiency. 98
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 98
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 98
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 96
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 96
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 94
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 94
Dolore Articolare Acuto 94
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 94
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 94
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 93
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 92
High risk low-grade lymphoma: Molecular remission after intensive sequential chemotherapy. 92
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 92
Vitamin d signaling in gastro-rheumatology: From immuno-modulation to potential clinical applications 92
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 88
Unbalance between Ha- and Ki-Ras is responsible for scleroderma fibroblast activation 88
Therapeutic approach with IVIG in patients affected by connective tissue disease 88
Reply 88
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 88
Characterization of a novel allele HLA-CW*160102 87
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 87
Expression of C-MYB and B-MYB oncogenes on myelofibrotic marrow fibroblasts 86
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes. 86
Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study 85
The important role of molecular analyses to evaluate the efficacy of Rituximab treatment in a patient affected by severe multineuropathy in mixed cryoglobulinemia disease. 84
Totale 12.201
Categoria #
all - tutte 58.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 0 0 0 0 0 0 0 0 0 133 147 73
2021/2022856 52 178 32 47 13 56 30 49 50 70 107 172
2022/20231.956 164 216 140 187 137 439 3 101 403 14 114 38
2023/2024924 162 25 49 129 135 215 36 37 6 23 8 99
2024/20251.966 202 186 92 24 105 68 245 59 400 98 228 259
2025/20264.974 380 376 347 594 579 426 927 534 453 358 0 0
Totale 13.711